205.445 Tiotropium in children with moderate persistant asthma

• Research type

  Research Study

• Full title

  A randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution (2.5 µg and 5 µg) delivered via Respimat® inhaler once daily in the evening over 48 weeks in children (6 to 11 years old) with moderate persistent asthma

• IRAS ID

  148752

• Contact name

  Atul Gupta

• Contact email

  atulgupta1@nhs.net

• Eudract number

  2011-001758-26

• ISRCTN Number

  n/a

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  14/SC/0248

• Date of REC Opinion

  2 Jun 2014

• REC opinion

  Further Information Favourable Opinion